Effect of an Eye Movement Desensitization and Reprocessing (EMDR)-based therapy on pain and other physical symptoms in patients with fibromyalgia and post-traumatic stress disorder

Effect of an EMDR-based psychotherapy on physical symptoms in patients with fibromyalgia and post-traumatic stress disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15169107

Enrollment

Registered

2022-01-20

Start date

2017-09-01

Completion date

Unknown

Last updated

2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia and posttraumatic stress disorder Mental and Behavioural Disorders

Interventions

Patients included were randomly assigned to treatment with EMDR through a structured protocol versus remaining on the waiting list for treatment which was offered and applied to this group once the fo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18 or older 2. Willing to undergo randomization 3. Fulfill modified FM diagnostic criteria from the American College of Rheumatology (2010) 4. Fulfill diagnostic criteria of DSM 5 of PTSD

Exclusion criteria

Exclusion criteria: 1. Receiving active psychotherapeutic treatment in the last 2 months 2. Started a new pharmacological treatment or a significant dose modification in the last month of a drug already prescribed for FM or PTSD 3. Presence of a significant personality or psychotic disorder or severe depressive syndrome

Design outcomes

Primary

Measure	Time frame
Data were collected at baseline and at the end of treatment or after 6 months of waiting list period. 1. Pain intensity assessed using: 1.1 Visual Analog Scale for pain (VAS pain) 1.2 Brief pain inventory 1.3 Fibromyalgia Impact Questionnaire (FIQ) 2. Fatigue was evaluated using the Multidimensional Fatigue Inventory (MFI-20) 3. Post Traumatic Stress Disorder symptoms were evaluated using the PCL-5	—

Measure

Time frame

Data were collected at baseline and at the end of treatment or after 6 months of waiting list period. 1. Pain intensity assessed using: 1.1 Visual Analog Scale for pain (VAS pain) 1.2 Brief pain inventory 1.3 Fibromyalgia Impact Questionnaire (FIQ) 2. Fatigue was evaluated using the Multidimensional Fatigue Inventory (MFI-20) 3. Post Traumatic Stress Disorder symptoms were evaluated using the PCL-5

—

Secondary

Measure	Time frame
Data were collected at baseline and at the end of treatment or after 6 months of waiting list period. 1. Anxiety was evaluated using the Hamilton Anxiety Scale 2. Depression was evaluated by administering the Hamilton Rating Scale for Depression (HAM-D)	—

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026